DPP8 is a novel therapeutic target for multiple myeloma.

导出 LinkOut

翻译打印收藏纠错

作者： Tsutomu,Sato ^[1] ; Ayumi,Tatekoshi ^[2] ; Kohichi,Takada ^[2] ; Satoshi,Iyama ^[2] ; Yusuke,Kamihara ^[3] ; Paras,Jawaid ^[4] ; Mati Ur,Rehman ^[4] ; Kyo,Noguchi ^[4] ; Takashi,Kondo ^[4] ; Sayaka,Kajikawa ^[5] ; Kotaro,Arita ^[5] ; Akinori,Wada ^[5] ; Jun,Murakami ^[5] ; Miho,Arai ^[6] ; Ichiro,Yasuda ^[7] ; Nam H,Dang ^[8] ; Ryo,Hatano ^[9] ; Noriaki,Iwao ^[9] ; Kei,Ohnuma ^[9] ; Chikao,Morimoto ^[9]

作者单位： Department of Hematology, Toyama University Hospital, Toyama, Japan. tsutomus@med.u-toyama.ac.jp. ^[1] Department of Medical Oncology and Hematology, Sapporo Medical University, Sapporo, Japan. ^[2] Department of Hematology, National Cancer Center Hospital East, Kashiwa, Japan. ^[3] Department of Radiology, University of Toyama, Toyama, Japan. ^[4] Department of Hematology, Toyama University Hospital, Toyama, Japan. ^[5] Department of Pediatrics, University of Toyama, Toyama, Japan. ^[6] Department of Gastroenterology and Hematology, University of Toyama, Toyama, Japan. ^[7] Division of Hematology/Oncology, University of Florida, Gainesville, Florida, USA. ^[8] Department of Therapy Development and Innovation for Immune Disorders and Cancers, Juntendo University, Tokyo, Japan. ^[9]